{
  "schemaVersion": "peptidescanner-fda-enforcement-evidence/v1",
  "source": {
    "name": "openFDA drug enforcement reports",
    "lastUpdated": "2026-08-12",
    "observedAt": "2026-08-25T16:28:45.000Z",
    "observationSha256": "8c383584f892b7cffd5b87d8fbf670e5be5c73bcc81706a1430aca0bced97f16",
    "publicObservationSha256": "8762ea09daf2d8cbf07c306b61f1c27de9cd10cb30795698b3886cfb7d05af41"
  },
  "publishedAt": "2026-08-25",
  "reportingBoundary": "This PeptideScanner lane is a bounded, dated FDA enforcement-report snapshot connected through an exact openFDA application-number annotation. It is not a medical alert or complete recall-lifecycle tracker, does not establish current product or recall status, does not identify affected lots, and does not provide medical guidance.",
  "coverage": {
    "queriedApplicationCount": 110,
    "matchedApplicationCount": 15,
    "recallCount": 22,
    "mappedPeptideCount": 8,
    "requestCount": 110,
    "responseBytes": 77940,
    "oldestReportDate": "2014-05-07",
    "newestReportDate": "2026-07-08"
  },
  "queryReceipts": [
    {
      "applicationNumber": "ANDA074728",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA074728%22&limit=100"
    },
    {
      "applicationNumber": "ANDA075471",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA075471%22&limit=100"
    },
    {
      "applicationNumber": "ANDA075721",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA075721%22&limit=100"
    },
    {
      "applicationNumber": "ANDA075957",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA075957%22&limit=100"
    },
    {
      "applicationNumber": "ANDA075959",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA075959%22&limit=100"
    },
    {
      "applicationNumber": "ANDA076313",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA076313%22&limit=100"
    },
    {
      "applicationNumber": "ANDA076330",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA076330%22&limit=100"
    },
    {
      "applicationNumber": "ANDA077329",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA077329%22&limit=100"
    },
    {
      "applicationNumber": "ANDA077330",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA077330%22&limit=100"
    },
    {
      "applicationNumber": "ANDA077331",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA077331%22&limit=100"
    },
    {
      "applicationNumber": "ANDA077372",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA077372%22&limit=100"
    },
    {
      "applicationNumber": "ANDA077373",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA077373%22&limit=100"
    },
    {
      "applicationNumber": "ANDA077450",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA077450%22&limit=100"
    },
    {
      "applicationNumber": "ANDA077457",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA077457%22&limit=100"
    },
    {
      "applicationNumber": "ANDA078885",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA078885%22&limit=100"
    },
    {
      "applicationNumber": "ANDA079198",
      "responseSha256": "1aa5122535ddb2f69178fa830ca067b6ad8ac732f70e40ff087bca072cdc5cef",
      "resultCount": 1,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA079198%22&limit=100"
    },
    {
      "applicationNumber": "ANDA090834",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA090834%22&limit=100"
    },
    {
      "applicationNumber": "ANDA090985",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA090985%22&limit=100"
    },
    {
      "applicationNumber": "ANDA090986",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA090986%22&limit=100"
    },
    {
      "applicationNumber": "ANDA091041",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA091041%22&limit=100"
    },
    {
      "applicationNumber": "ANDA203765",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA203765%22&limit=100"
    },
    {
      "applicationNumber": "ANDA204468",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA204468%22&limit=100"
    },
    {
      "applicationNumber": "ANDA204669",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA204669%22&limit=100"
    },
    {
      "applicationNumber": "ANDA206697",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA206697%22&limit=100"
    },
    {
      "applicationNumber": "ANDA208086",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA208086%22&limit=100"
    },
    {
      "applicationNumber": "ANDA208569",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA208569%22&limit=100"
    },
    {
      "applicationNumber": "ANDA209564",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA209564%22&limit=100"
    },
    {
      "applicationNumber": "ANDA209611",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA209611%22&limit=100"
    },
    {
      "applicationNumber": "ANDA210317",
      "responseSha256": "4eb98d4e9f60e7ded0efbab58fd0bb324c9f5a3a6766971e94b0b8ee0244d87a",
      "resultCount": 4,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA210317%22&limit=100"
    },
    {
      "applicationNumber": "ANDA211097",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA211097%22&limit=100"
    },
    {
      "applicationNumber": "ANDA212552",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA212552%22&limit=100"
    },
    {
      "applicationNumber": "ANDA212963",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA212963%22&limit=100"
    },
    {
      "applicationNumber": "ANDA212972",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA212972%22&limit=100"
    },
    {
      "applicationNumber": "ANDA213155",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA213155%22&limit=100"
    },
    {
      "applicationNumber": "ANDA213641",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA213641%22&limit=100"
    },
    {
      "applicationNumber": "ANDA213829",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA213829%22&limit=100"
    },
    {
      "applicationNumber": "ANDA214457",
      "responseSha256": "c25fe46d1a2e45201a5819af550151335b643450818707c37ad4d746e5e3ad42",
      "resultCount": 1,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA214457%22&limit=100"
    },
    {
      "applicationNumber": "ANDA214568",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA214568%22&limit=100"
    },
    {
      "applicationNumber": "ANDA215245",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA215245%22&limit=100"
    },
    {
      "applicationNumber": "ANDA215336",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA215336%22&limit=100"
    },
    {
      "applicationNumber": "ANDA215421",
      "responseSha256": "ddbd014f1a97b086fccc84d21a0d1cc1e36b5191798d44639aae487d01f90afb",
      "resultCount": 1,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA215421%22&limit=100"
    },
    {
      "applicationNumber": "ANDA215503",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA215503%22&limit=100"
    },
    {
      "applicationNumber": "ANDA215826",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA215826%22&limit=100"
    },
    {
      "applicationNumber": "ANDA216589",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA216589%22&limit=100"
    },
    {
      "applicationNumber": "ANDA216807",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA216807%22&limit=100"
    },
    {
      "applicationNumber": "ANDA216839",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA216839%22&limit=100"
    },
    {
      "applicationNumber": "ANDA217063",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA217063%22&limit=100"
    },
    {
      "applicationNumber": "ANDA217193",
      "responseSha256": "bd8794719fa61209dd9cfabe7fb412322d5f97c5c2eac5461ecd414a2c629b2a",
      "resultCount": 1,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA217193%22&limit=100"
    },
    {
      "applicationNumber": "ANDA217234",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA217234%22&limit=100"
    },
    {
      "applicationNumber": "ANDA217437",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA217437%22&limit=100"
    },
    {
      "applicationNumber": "ANDA217590",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA217590%22&limit=100"
    },
    {
      "applicationNumber": "ANDA217860",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA217860%22&limit=100"
    },
    {
      "applicationNumber": "ANDA217957",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA217957%22&limit=100"
    },
    {
      "applicationNumber": "ANDA218115",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA218115%22&limit=100"
    },
    {
      "applicationNumber": "ANDA218813",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22ANDA218813%22&limit=100"
    },
    {
      "applicationNumber": "BLA022505",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22BLA022505%22&limit=100"
    },
    {
      "applicationNumber": "BLA125469",
      "responseSha256": "3195c28b847a79ff4d834fa1b3a753d06e02c467cfe475c9bd498f869ab9c005",
      "resultCount": 2,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22BLA125469%22&limit=100"
    },
    {
      "applicationNumber": "BLA208471",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22BLA208471%22&limit=100"
    },
    {
      "applicationNumber": "BLA761412",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22BLA761412%22&limit=100"
    },
    {
      "applicationNumber": "NDA012122",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA012122%22&limit=100"
    },
    {
      "applicationNumber": "NDA019010",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA019010%22&limit=100"
    },
    {
      "applicationNumber": "NDA019667",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA019667%22&limit=100"
    },
    {
      "applicationNumber": "NDA019732",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA019732%22&limit=100"
    },
    {
      "applicationNumber": "NDA019943",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA019943%22&limit=100"
    },
    {
      "applicationNumber": "NDA020011",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA020011%22&limit=100"
    },
    {
      "applicationNumber": "NDA020263",
      "responseSha256": "8f5f6c229ff6323b7c02b13a4feabb519d5b88a9a14488a5dcda0f0e298124f9",
      "resultCount": 1,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA020263%22&limit=100"
    },
    {
      "applicationNumber": "NDA020517",
      "responseSha256": "df2175649d87c1495b690ea7f43e8bb78bbde5ccacb81977f29fd96ede82173b",
      "resultCount": 3,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA020517%22&limit=100"
    },
    {
      "applicationNumber": "NDA020708",
      "responseSha256": "03a2a39ce92e46ede982641206b4f3036917aa4084e79737ae951b33bfe82e2c",
      "resultCount": 1,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA020708%22&limit=100"
    },
    {
      "applicationNumber": "NDA020918",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA020918%22&limit=100"
    },
    {
      "applicationNumber": "NDA020928",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA020928%22&limit=100"
    },
    {
      "applicationNumber": "NDA021008",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA021008%22&limit=100"
    },
    {
      "applicationNumber": "NDA021060",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA021060%22&limit=100"
    },
    {
      "applicationNumber": "NDA021088",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA021088%22&limit=100"
    },
    {
      "applicationNumber": "NDA021318",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA021318%22&limit=100"
    },
    {
      "applicationNumber": "NDA021332",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA021332%22&limit=100"
    },
    {
      "applicationNumber": "NDA021343",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA021343%22&limit=100"
    },
    {
      "applicationNumber": "NDA021379",
      "responseSha256": "1c9994cedc1b2d126dcf9a9e6b62aaf4bdfbca1145218310189dcbda5e07fd09",
      "resultCount": 1,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA021379%22&limit=100"
    },
    {
      "applicationNumber": "NDA021488",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA021488%22&limit=100"
    },
    {
      "applicationNumber": "NDA021731",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA021731%22&limit=100"
    },
    {
      "applicationNumber": "NDA021773",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA021773%22&limit=100"
    },
    {
      "applicationNumber": "NDA021919",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA021919%22&limit=100"
    },
    {
      "applicationNumber": "NDA022074",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA022074%22&limit=100"
    },
    {
      "applicationNumber": "NDA022200",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA022200%22&limit=100"
    },
    {
      "applicationNumber": "NDA022341",
      "responseSha256": "f146fcc6329a4448b8e5cd3eabc66d9db84bb1a1543e5beaf1ece8ea1a382268",
      "resultCount": 1,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA022341%22&limit=100"
    },
    {
      "applicationNumber": "NDA201849",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA201849%22&limit=100"
    },
    {
      "applicationNumber": "NDA202811",
      "responseSha256": "ce9f427b50ee3b06f615bdb7343754e53b3a5c23ea04b5710d66d1f29b5ca566",
      "resultCount": 1,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA202811%22&limit=100"
    },
    {
      "applicationNumber": "NDA205054",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA205054%22&limit=100"
    },
    {
      "applicationNumber": "NDA206321",
      "responseSha256": "3298962a8382fffeaf569b7a842bfa410d8dc1b2e7d68a31ce2a5a102b84a103",
      "resultCount": 1,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA206321%22&limit=100"
    },
    {
      "applicationNumber": "NDA208232",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA208232%22&limit=100"
    },
    {
      "applicationNumber": "NDA208743",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA208743%22&limit=100"
    },
    {
      "applicationNumber": "NDA208745",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA208745%22&limit=100"
    },
    {
      "applicationNumber": "NDA209210",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA209210%22&limit=100"
    },
    {
      "applicationNumber": "NDA209637",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA209637%22&limit=100"
    },
    {
      "applicationNumber": "NDA210134",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA210134%22&limit=100"
    },
    {
      "applicationNumber": "NDA210557",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA210557%22&limit=100"
    },
    {
      "applicationNumber": "NDA210797",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA210797%22&limit=100"
    },
    {
      "applicationNumber": "NDA211939",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA211939%22&limit=100"
    },
    {
      "applicationNumber": "NDA212097",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA212097%22&limit=100"
    },
    {
      "applicationNumber": "NDA213051",
      "responseSha256": "3c62a55cf1fd5a857ff5b37a90649d9b3688c1f38953f195eebc64ec1fa2541f",
      "resultCount": 1,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA213051%22&limit=100"
    },
    {
      "applicationNumber": "NDA213150",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA213150%22&limit=100"
    },
    {
      "applicationNumber": "NDA213182",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA213182%22&limit=100"
    },
    {
      "applicationNumber": "NDA213224",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA213224%22&limit=100"
    },
    {
      "applicationNumber": "NDA213793",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA213793%22&limit=100"
    },
    {
      "applicationNumber": "NDA214938",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA214938%22&limit=100"
    },
    {
      "applicationNumber": "NDA215256",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA215256%22&limit=100"
    },
    {
      "applicationNumber": "NDA215395",
      "responseSha256": "8be5f74447b17ac2a4f3b5fbd607b556b0e952abbde66bb87f4bb28d7379e06e",
      "resultCount": 2,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA215395%22&limit=100"
    },
    {
      "applicationNumber": "NDA215866",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA215866%22&limit=100"
    },
    {
      "applicationNumber": "NDA217806",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA217806%22&limit=100"
    },
    {
      "applicationNumber": "NDA218316",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA218316%22&limit=100"
    },
    {
      "applicationNumber": "NDA218771",
      "responseSha256": "57b1e7534d003e4246182162fd2469cdf038de39405056f44fc006715e5496da",
      "resultCount": 0,
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=openfda.application_number%3A%22NDA218771%22&limit=100"
    }
  ],
  "records": [
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-1287-2014",
      "eventId": "67709",
      "applicationNumbers": [
        "NDA020517"
      ],
      "peptideSlugs": [
        "leuprolide"
      ],
      "status": "Terminated",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "AbbVie Inc",
      "reasonForRecall": "Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.",
      "recallInitiationDate": "2014-03-10",
      "centerClassificationDate": "2014-04-29",
      "reportDate": "2014-05-07",
      "terminationDate": "2016-06-22",
      "brandNames": [
        "LUPRON DEPOT"
      ],
      "genericNames": [
        "LEUPROLIDE ACETATE"
      ],
      "substanceNames": [],
      "productNdcs": [
        "0074-3346",
        "0074-3473",
        "0074-3642",
        "0074-3683"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1287-2014%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "LUPRON DEPOT",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "d2ccaca025bc0df1830a2f6aa0bde09af0282caefd1efdad912425a6548d766f",
      "recordSha256": "50e4ee91c2bee04b696f02b9541cd822fe80923fb88d99db6cc21bb3a3574415"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-1288-2014",
      "eventId": "67709",
      "applicationNumbers": [
        "NDA020517"
      ],
      "peptideSlugs": [
        "leuprolide"
      ],
      "status": "Terminated",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "AbbVie Inc",
      "reasonForRecall": "Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.",
      "recallInitiationDate": "2014-03-10",
      "centerClassificationDate": "2014-04-29",
      "reportDate": "2014-05-07",
      "terminationDate": "2016-06-22",
      "brandNames": [
        "LUPRON DEPOT"
      ],
      "genericNames": [
        "LEUPROLIDE ACETATE"
      ],
      "substanceNames": [],
      "productNdcs": [
        "0074-3346",
        "0074-3473",
        "0074-3642",
        "0074-3683"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1288-2014%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "LUPRON DEPOT",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "03719cd660a8e5a3b3132c929db113a52e1f080bf509c9dfcd5e4cb6d253962d",
      "recordSha256": "b33db8388692148ebf854d2dec4283a5e62addb8c95f4b2d51da12084b4dadf9"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-1289-2014",
      "eventId": "67709",
      "applicationNumbers": [
        "NDA020263"
      ],
      "peptideSlugs": [
        "leuprolide"
      ],
      "status": "Terminated",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "AbbVie Inc",
      "reasonForRecall": "Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.",
      "recallInitiationDate": "2014-03-10",
      "centerClassificationDate": "2014-04-29",
      "reportDate": "2014-05-07",
      "terminationDate": "2016-06-22",
      "brandNames": [
        "LUPRON DEPOT-PED"
      ],
      "genericNames": [
        "LEUPROLIDE ACETATE"
      ],
      "substanceNames": [],
      "productNdcs": [
        "0074-2108",
        "0074-2282",
        "0074-2440",
        "0074-3575",
        "0074-3779",
        "0074-9694"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1289-2014%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "LUPRON DEPOT-PED",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "8c6d14481452ae372c8d800776c8cdf2a98e98190c77a6809d9e8a0fc9068d09",
      "recordSha256": "812763181a69c5ec86e4abd3dcdb5776d647f4d1c4be8005fdcab2c87e0c905b"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-1290-2014",
      "eventId": "67709",
      "applicationNumbers": [
        "NDA020708"
      ],
      "peptideSlugs": [
        "leuprolide"
      ],
      "status": "Terminated",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "AbbVie Inc",
      "reasonForRecall": "Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.",
      "recallInitiationDate": "2014-03-10",
      "centerClassificationDate": "2014-04-29",
      "reportDate": "2014-05-07",
      "terminationDate": "2016-06-22",
      "brandNames": [
        "LUPRON DEPOT"
      ],
      "genericNames": [
        "LEUPROLIDE ACETATE"
      ],
      "substanceNames": [],
      "productNdcs": [
        "0074-3663"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1290-2014%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "LUPRON DEPOT",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "d39d745a3a16e5dafe688aabe815998e37592959bb018da25e7d09bc5c1e9180",
      "recordSha256": "186a4d2e9668316c4e1f46872561a9a45ebab95b89677c2efa98e8783feb3a81"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-1291-2014",
      "eventId": "67709",
      "applicationNumbers": [
        "NDA020517"
      ],
      "peptideSlugs": [
        "leuprolide"
      ],
      "status": "Terminated",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "AbbVie Inc",
      "reasonForRecall": "Defective Delivery System: Some Lupron Depot Kits may containin a syringe with a potentially defective LuproLoc needle stick protection device.",
      "recallInitiationDate": "2014-03-10",
      "centerClassificationDate": "2014-04-29",
      "reportDate": "2014-05-07",
      "terminationDate": "2016-06-22",
      "brandNames": [
        "LUPRON DEPOT"
      ],
      "genericNames": [
        "LEUPROLIDE ACETATE"
      ],
      "substanceNames": [],
      "productNdcs": [
        "0074-3346",
        "0074-3473",
        "0074-3642",
        "0074-3683"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1291-2014%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "LUPRON DEPOT",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "b8bdd22d41b86e3f1983d05b4f7eab700c89db9f98070bea39d905f9e0eb138c",
      "recordSha256": "e1ad23e53895351883e611e0d678c67475237f64cdacb7e5b7bc670a89a7e117"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0618-2021",
      "eventId": "87537",
      "applicationNumbers": [
        "NDA206321"
      ],
      "peptideSlugs": [
        "liraglutide"
      ],
      "status": "Terminated",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Novo Nordisk Inc",
      "reasonForRecall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.",
      "recallInitiationDate": "2021-03-22",
      "centerClassificationDate": "2021-06-10",
      "reportDate": "2021-04-21",
      "terminationDate": "2022-12-09",
      "brandNames": [
        "SAXENDA"
      ],
      "genericNames": [
        "LIRAGLUTIDE"
      ],
      "substanceNames": [
        "LIRAGLUTIDE"
      ],
      "productNdcs": [
        "0169-2800"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0618-2021%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "SAXENDA",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "3df81057b63b9faa2251ce49d7e07aa2491c0bbe362c6d58535876b8d5f37ee2",
      "recordSha256": "b77f506c6605d5013bf5390c975884b9a6b9c6049330dddff22e0d7c24bd4cde"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0622-2021",
      "eventId": "87537",
      "applicationNumbers": [
        "NDA022341"
      ],
      "peptideSlugs": [
        "liraglutide"
      ],
      "status": "Terminated",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Novo Nordisk Inc",
      "reasonForRecall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.",
      "recallInitiationDate": "2021-03-22",
      "centerClassificationDate": "2021-06-10",
      "reportDate": "2021-04-21",
      "terminationDate": "2022-12-09",
      "brandNames": [
        "VICTOZA"
      ],
      "genericNames": [
        "LIRAGLUTIDE"
      ],
      "substanceNames": [
        "LIRAGLUTIDE"
      ],
      "productNdcs": [
        "0169-4060"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0622-2021%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "VICTOZA",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "bd70eaa85ec1da10b49f2c55271e342bfdd0e38f11d2ce66e5f65745c14b7a71",
      "recordSha256": "5fb89d531e225410f8b9de3b26a3ed967ba28da2a8f8139c8891618fc0f5bca4"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0417-2021",
      "eventId": "87512",
      "applicationNumbers": [
        "NDA202811"
      ],
      "peptideSlugs": [
        "linaclotide"
      ],
      "status": "Terminated",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Cardinal Health Inc.",
      "reasonForRecall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.",
      "recallInitiationDate": "2021-03-15",
      "centerClassificationDate": "2021-05-24",
      "reportDate": "2021-06-02",
      "terminationDate": "2024-06-17",
      "brandNames": [
        "LINZESS"
      ],
      "genericNames": [
        "LINACLOTIDE"
      ],
      "substanceNames": [
        "LINACLOTIDE"
      ],
      "productNdcs": [
        "0456-1201",
        "0456-1202",
        "0456-1203"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0417-2021%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "LINZESS",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "eb669549c5605d6c161ab46530ca3a4afad2d38fd70842b962d1da25a3f72877",
      "recordSha256": "fe40079b951f8637bdec8bba62d9b6ebc0f794379d5f28ad8a0e41ee4e24f077"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0536-2021",
      "eventId": "87512",
      "applicationNumbers": [
        "NDA213051"
      ],
      "peptideSlugs": [
        "semaglutide"
      ],
      "status": "Terminated",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Cardinal Health Inc.",
      "reasonForRecall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.",
      "recallInitiationDate": "2021-03-15",
      "centerClassificationDate": "2021-05-24",
      "reportDate": "2021-06-02",
      "terminationDate": "2024-06-17",
      "brandNames": [
        "OZEMPIC"
      ],
      "genericNames": [
        "ORAL SEMAGLUTIDE"
      ],
      "substanceNames": [
        "SEMAGLUTIDE"
      ],
      "productNdcs": [
        "0169-1704",
        "0169-1709",
        "0169-1715",
        "0169-4303",
        "0169-4307",
        "0169-4314",
        "0169-4804",
        "0169-4809",
        "0169-4815"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0536-2021%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "OZEMPIC",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "3daefeca5dc6e52ac2c0bdd567ceaf88e2567387a019a1c33356d0fe232a0ff5",
      "recordSha256": "01a9acb5737369ac66c249f1d02ec288b33ca3e8867b7e88d9c895c5e9fb17eb"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0773-2021",
      "eventId": "88505",
      "applicationNumbers": [
        "BLA125469"
      ],
      "peptideSlugs": [
        "dulaglutide"
      ],
      "status": "Terminated",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Eli Lilly & Company",
      "reasonForRecall": "Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.",
      "recallInitiationDate": "2021-08-19",
      "centerClassificationDate": "2021-08-26",
      "reportDate": "2021-09-01",
      "terminationDate": "2023-08-07",
      "brandNames": [
        "TRULICITY"
      ],
      "genericNames": [
        "DULAGLUTIDE"
      ],
      "substanceNames": [
        "DULAGLUTIDE"
      ],
      "productNdcs": [
        "0002-1433",
        "0002-1434",
        "0002-2236",
        "0002-3182"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0773-2021%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "TRULICITY",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "93012b091be46ed38b78be96fac3e0f4fc608dd6a4563dea58976fe82e4c34ad",
      "recordSha256": "89c977edd0cc55456ed3370f7fcedf75623324806ac3e40629601441049d92a9"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0884-2022",
      "eventId": "89976",
      "applicationNumbers": [
        "BLA125469"
      ],
      "peptideSlugs": [
        "dulaglutide"
      ],
      "status": "Completed",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Cardinal Health Inc.",
      "reasonForRecall": "TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions",
      "recallInitiationDate": "2022-04-05",
      "centerClassificationDate": "2022-05-19",
      "reportDate": "2022-05-25",
      "terminationDate": null,
      "brandNames": [
        "TRULICITY"
      ],
      "genericNames": [
        "DULAGLUTIDE"
      ],
      "substanceNames": [
        "DULAGLUTIDE"
      ],
      "productNdcs": [
        "0002-1433",
        "0002-1434",
        "0002-2236",
        "0002-3182"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0884-2022%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "TRULICITY",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "4c1bd41f618b0d120ec864e519a22d0c1ad4ebfd0ab243baa2d7b2d83873378a",
      "recordSha256": "e302bdfacff1c2612e22ac2723d271e1c2a1cbd2523164f5f272575deca65aed"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0058-2023",
      "eventId": "90974",
      "applicationNumbers": [
        "ANDA079198"
      ],
      "peptideSlugs": [
        "octreotide"
      ],
      "status": "Terminated",
      "classification": "Class I",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Viatris Inc",
      "reasonForRecall": "Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.",
      "recallInitiationDate": "2022-10-07",
      "centerClassificationDate": "2022-11-08",
      "reportDate": "2022-11-16",
      "terminationDate": "2024-01-12",
      "brandNames": [
        "OCTREOTIDE ACETATE"
      ],
      "genericNames": [
        "OCTREOTIDE ACETATE"
      ],
      "substanceNames": [
        "OCTREOTIDE ACETATE"
      ],
      "productNdcs": [
        "67457-239",
        "67457-245",
        "67457-246"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0058-2023%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "OCTREOTIDE ACETATE",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "a937086fc20524a6b6277ff7b69c3dae943cafecf656eef96a6c231ecef191ce",
      "recordSha256": "14c021ff4c33c691835180284166c6037033a619ce65f36dab849654666572f4"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-1178-2023",
      "eventId": "93044",
      "applicationNumbers": [
        "NDA021379"
      ],
      "peptideSlugs": [
        "leuprolide"
      ],
      "status": "Terminated",
      "classification": "Class III",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Tolmar, Inc.",
      "reasonForRecall": "Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.",
      "recallInitiationDate": "2023-09-12",
      "centerClassificationDate": "2023-09-27",
      "reportDate": "2023-10-04",
      "terminationDate": "2024-10-03",
      "brandNames": [
        "ELIGARD"
      ],
      "genericNames": [
        "LEUPROLIDE ACETATE"
      ],
      "substanceNames": [],
      "productNdcs": [
        "62935-223",
        "62935-303",
        "62935-453",
        "62935-753"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-1178-2023%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "ELIGARD",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "62ec8c01e26e07b11d8b1dce2210d8df3b4d34b90b4b81d5dafc1d7f8ccad8a2",
      "recordSha256": "37299cd99c9e8c8269364f18f0c722b7dfdb38517188f6a9eb20079c8fe5e894"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0290-2026",
      "eventId": "98247",
      "applicationNumbers": [
        "NDA215395"
      ],
      "peptideSlugs": [
        "lanreotide"
      ],
      "status": "Ongoing",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Cipla USA, Inc.",
      "reasonForRecall": "Presence of Particulate Matter.",
      "recallInitiationDate": "2026-01-02",
      "centerClassificationDate": "2026-01-15",
      "reportDate": "2026-01-21",
      "terminationDate": null,
      "brandNames": [
        "LANREOTIDE ACETATE"
      ],
      "genericNames": [
        "LANREOTIDE ACETATE"
      ],
      "substanceNames": [
        "LANREOTIDE ACETATE"
      ],
      "productNdcs": [
        "69097-870",
        "69097-880",
        "69097-890"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0290-2026%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "LANREOTIDE ACETATE",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "aa4de191d24345e8f21167a2ef29341f98b846af1beaf48680cb62dfe78aed32",
      "recordSha256": "d48f9d22433e0401bec6aebd44fe820e33bab6417b7c6f9980386db67ee0016e"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0404-2026",
      "eventId": "98609",
      "applicationNumbers": [
        "ANDA210317"
      ],
      "peptideSlugs": [
        "octreotide"
      ],
      "status": "Ongoing",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Teva Pharmaceuticals USA, Inc",
      "reasonForRecall": "Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.",
      "recallInitiationDate": "2026-03-17",
      "centerClassificationDate": "2026-03-27",
      "reportDate": "2026-04-01",
      "terminationDate": null,
      "brandNames": [
        "OCTREOTIDE ACETATE"
      ],
      "genericNames": [
        "OCTREOTIDE ACETATE"
      ],
      "substanceNames": [],
      "productNdcs": [
        "0480-9257",
        "0480-9259",
        "0480-9262"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0404-2026%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "OCTREOTIDE ACETATE",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "3cd4daf8b65e833ccaa5350090d84e69c1a3ac1db4e13d22c7f6b643e46ea9ff",
      "recordSha256": "541676b0ef483813873ee814a4396565b4f494e765349211d18fe6d0444a69fb"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0405-2026",
      "eventId": "98609",
      "applicationNumbers": [
        "ANDA210317"
      ],
      "peptideSlugs": [
        "octreotide"
      ],
      "status": "Ongoing",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Teva Pharmaceuticals USA, Inc",
      "reasonForRecall": "Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.",
      "recallInitiationDate": "2026-03-17",
      "centerClassificationDate": "2026-03-27",
      "reportDate": "2026-04-01",
      "terminationDate": null,
      "brandNames": [
        "OCTREOTIDE ACETATE"
      ],
      "genericNames": [
        "OCTREOTIDE ACETATE"
      ],
      "substanceNames": [],
      "productNdcs": [
        "0480-9257",
        "0480-9259",
        "0480-9262"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0405-2026%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "OCTREOTIDE ACETATE",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "0a835bef258e0104ed1fb751c6f1c26225e1666e2090a5f640a11ae9c3f88b37",
      "recordSha256": "0df8509aa357d2bd8e5be8ae2935d346c832038cc3615dc570aba351848ffe62"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0406-2026",
      "eventId": "98609",
      "applicationNumbers": [
        "ANDA210317"
      ],
      "peptideSlugs": [
        "octreotide"
      ],
      "status": "Ongoing",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Teva Pharmaceuticals USA, Inc",
      "reasonForRecall": "Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.",
      "recallInitiationDate": "2026-03-17",
      "centerClassificationDate": "2026-03-27",
      "reportDate": "2026-04-01",
      "terminationDate": null,
      "brandNames": [
        "OCTREOTIDE ACETATE"
      ],
      "genericNames": [
        "OCTREOTIDE ACETATE"
      ],
      "substanceNames": [],
      "productNdcs": [
        "0480-9257",
        "0480-9259",
        "0480-9262"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0406-2026%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "OCTREOTIDE ACETATE",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "5d9e3af16859874da2134533029e270b6528db8107e481cb624a17c92a7b1ab9",
      "recordSha256": "29f3ee6e926945fb3ed33da263a57ada1c16a691652874ac3d63b1e77862cacf"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0422-2026",
      "eventId": "98575",
      "applicationNumbers": [
        "NDA215395"
      ],
      "peptideSlugs": [
        "lanreotide"
      ],
      "status": "Ongoing",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Cipla USA, Inc.",
      "reasonForRecall": "Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.",
      "recallInitiationDate": "2026-03-13",
      "centerClassificationDate": "2026-04-03",
      "reportDate": "2026-04-15",
      "terminationDate": null,
      "brandNames": [
        "LANREOTIDE ACETATE"
      ],
      "genericNames": [
        "LANREOTIDE ACETATE"
      ],
      "substanceNames": [
        "LANREOTIDE ACETATE"
      ],
      "productNdcs": [
        "69097-870",
        "69097-880",
        "69097-890"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0422-2026%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "LANREOTIDE ACETATE",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "36fc7f6a6b04c06d7292134ce07f0a33dd25424440e470976801cc187467f932",
      "recordSha256": "451caba6357fa035106f961adfdc79edb89e61f0cda812be9a286103f41a3f5a"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0423-2026",
      "eventId": "98575",
      "applicationNumbers": [
        "ANDA217193"
      ],
      "peptideSlugs": [
        "lanreotide"
      ],
      "status": "Ongoing",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Cipla USA, Inc.",
      "reasonForRecall": "Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.",
      "recallInitiationDate": "2026-03-13",
      "centerClassificationDate": "2026-04-03",
      "reportDate": "2026-04-15",
      "terminationDate": null,
      "brandNames": [
        "LANREOTIDE ACETATE"
      ],
      "genericNames": [
        "LANREOTIDE ACETATE"
      ],
      "substanceNames": [
        "LANREOTIDE ACETATE"
      ],
      "productNdcs": [
        "69097-906",
        "69097-907",
        "69097-908"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0423-2026%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "LANREOTIDE ACETATE",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "cdc37a992e407d8df1c2f4d3551d387e5aa1f78e6a78f4e1c1c270504ff12dee",
      "recordSha256": "f43226a913d1f7f3d9ed58cb1370de07feaeb39ba41b4477214e28516e3dd4fa"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0519-2026",
      "eventId": "98810",
      "applicationNumbers": [
        "ANDA210317"
      ],
      "peptideSlugs": [
        "octreotide"
      ],
      "status": "Ongoing",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Teva Pharmaceuticals USA, Inc",
      "reasonForRecall": "Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.",
      "recallInitiationDate": "2026-04-24",
      "centerClassificationDate": "2026-05-05",
      "reportDate": "2026-05-13",
      "terminationDate": null,
      "brandNames": [
        "OCTREOTIDE ACETATE"
      ],
      "genericNames": [
        "OCTREOTIDE ACETATE"
      ],
      "substanceNames": [],
      "productNdcs": [
        "0480-9257",
        "0480-9259",
        "0480-9262"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0519-2026%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "OCTREOTIDE ACETATE",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "703cb5d30dc9a547bf5be6078a0a3e44c6f80d24bcbfebf2e686cb9c1f2b299c",
      "recordSha256": "0e1b634fb923b233f757d49cf063224f7430c39f0b7412fe61c22a8e6a452484"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0541-2026",
      "eventId": "98809",
      "applicationNumbers": [
        "ANDA215421"
      ],
      "peptideSlugs": [
        "liraglutide"
      ],
      "status": "Ongoing",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Lupin Pharmaceuticals Inc.",
      "reasonForRecall": "Presence of particulate matter: a white thread-like structure in the cartridge",
      "recallInitiationDate": "2026-04-24",
      "centerClassificationDate": "2026-05-19",
      "reportDate": "2026-05-27",
      "terminationDate": null,
      "brandNames": [
        "LIRAGLUTIDE"
      ],
      "genericNames": [
        "LIRAGLUTIDE"
      ],
      "substanceNames": [
        "LIRAGLUTIDE"
      ],
      "productNdcs": [
        "70748-346"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0541-2026%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "LIRAGLUTIDE",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "bc599cdc32eb5ce6b8812a6cc2333161e609c048827601af074b16d5fe29a9ae",
      "recordSha256": "6083baf5ebfd702ef53ed540f6bd8a5dcff08a903f15e8b4f2835c2c53d5caba"
    },
    {
      "schemaVersion": "tier-a-fda-enforcement-public-record/v1",
      "recallNumber": "D-0723-2026",
      "eventId": "99296",
      "applicationNumbers": [
        "ANDA214457"
      ],
      "peptideSlugs": [
        "glucagon"
      ],
      "status": "Ongoing",
      "classification": "Class II",
      "voluntaryMandated": "Voluntary: Firm initiated",
      "recallingFirm": "Lupin Pharmaceuticals Inc.",
      "reasonForRecall": "CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.",
      "recallInitiationDate": "2026-06-23",
      "centerClassificationDate": "2026-07-23",
      "reportDate": "2026-07-08",
      "terminationDate": null,
      "brandNames": [
        "GLUCAGON"
      ],
      "genericNames": [
        "GLUCAGON"
      ],
      "substanceNames": [],
      "productNdcs": [
        "70748-311"
      ],
      "sourceUrl": "https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0723-2026%22&limit=1",
      "sourceLastUpdated": "2026-08-12",
      "observedAt": "2026-08-25T16:28:45.000Z",
      "productDescription": "GLUCAGON",
      "publishedAt": "2026-08-25",
      "sourceRecordSha256": "4a44b745df8a9895d4e5d8e8b5affef69bb466b3f7e11a7315f311255bf2ce10",
      "recordSha256": "1557c460177155fa1e2ed53515049388fe74c07fde74046d76c18a4c8ddcadc1"
    }
  ],
  "integrity": {
    "contentSha256": "9b221dc8f36c99ece1e465b55898686e772c4622f8b55d560749b48ca316d34e",
    "reviewedCandidateId": "fda-enforcement-held-2026-08-25-0f0bbda96aa84720",
    "reviewedCandidateSha256": "0f0bbda96aa8472045095cdd4f862d3968cf77d3ed7cd52f7ce4f5567f78a222"
  }
}